menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Young Americans have no memory of AIDS at its worst – they’re still at risk of infection, even when HIV doesn’t feel like a threat

19 0
17.11.2026

For Americans who came of age in the 1980s and early 1990s, HIV/AIDS was difficult to ignore. Hospitals were filled with young people sick with infections and cancers rarely seen in healthy adults. Friends and partners were quickly dying. Public health officials warned that the disease, primarily transmitted through sexual contact or sharing drug needles, had no effective treatment.

At the height of the U.S. epidemic in 1995, more than 56,000 people with AIDS died in a single year. Then antiretroviral therapy – medications that stop HIV from multiplying – transformed the epidemic. Over the next three years, AIDS diagnoses fell by 45%, while deaths among people with AIDS fell 63%.

Someone who is 20 years old today was born into a very different world. HIV is now a manageable chronic infection for people who can access and remain on treatment. As of 2025, over 20% of people around the world with HIV were unable to access treatment. As an infectious diseases physician caring for people with HIV, I have watched that transformation change not only the lives of my patients, but also the way people think about this once fatal disease.

That success raises an unusual public health question: How do you prevent new infections in a generation that grew up with no memory of a disease at its worst?

The change in life expectancy with HIV since the 1980s has been extraordinary.

Modern antiretroviral treatment can reduce the amount of HIV in the blood to levels that standard tests cannot detect. People who maintain this viral suppression can live long, healthy lives. Just as importantly, a person with a sustained undetectable viral load won’t sexually transmit HIV – a principle known as undetectable equals untransmittable, or U=U.

People without HIV also now have highly effective prevention options. Pre-exposure prophylaxis, or PrEP, can dramatically reduce the risk of acquiring HIV. Initially available as a daily pill, PrEP has since expanded to longer-lasting options. In 2021, the U.S. Food and Drug Administration approved an........

© The Conversation